2-111784346-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PP2PP3_Moderate
The NM_022662.4(ANAPC1):c.4972C>T(p.Pro1658Ser) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 28)
Exomes 𝑓: 0.000021 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ANAPC1
NM_022662.4 missense
NM_022662.4 missense
Scores
11
7
1
Clinical Significance
Conservation
PhyloP100: 9.74
Genes affected
ANAPC1 (HGNC:19988): (anaphase promoting complex subunit 1) This gene encodes a subunit of the anaphase-promoting complex. This complex is an E3 ubiquitin ligase that regulates progression through the metaphase to anaphase portion of the cell cycle by ubiquitinating proteins which targets them for degradation. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ANAPC1. . Gene score misZ 0.98694 (greater than the threshold 3.09). Trascript score misZ 5.2521 (greater than threshold 3.09). GenCC has associacion of gene with Rothmund-Thomson syndrome type 1.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.904
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC1 | NM_022662.4 | c.4972C>T | p.Pro1658Ser | missense_variant | 41/48 | ENST00000341068.8 | NP_073153.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC1 | ENST00000341068.8 | c.4972C>T | p.Pro1658Ser | missense_variant | 41/48 | 1 | NM_022662.4 | ENSP00000339109.3 | ||
ANAPC1 | ENST00000427997.5 | c.3574C>T | p.Pro1192Ser | missense_variant | 30/37 | 1 | ENSP00000396695.1 | |||
ANAPC1 | ENST00000643447.1 | n.-3C>T | upstream_gene_variant | ENSP00000494863.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152212Hom.: 0 Cov.: 28 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
152212
Hom.:
Cov.:
28
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251172Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135740
GnomAD3 exomes
AF:
AC:
5
AN:
251172
Hom.:
AF XY:
AC XY:
3
AN XY:
135740
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000212 AC: 31AN: 1461652Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727134
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
31
AN:
1461652
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
727134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152330Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 74482
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
152330
Hom.:
Cov.:
28
AF XY:
AC XY:
0
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | The c.4972C>T (p.P1658S) alteration is located in exon 41 (coding exon 40) of the ANAPC1 gene. This alteration results from a C to T substitution at nucleotide position 4972, causing the proline (P) at amino acid position 1658 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
H
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
B
Vest4
MutPred
Loss of glycosylation at T1655 (P = 0.0539);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at